Performance guarantees for individualized treatment rules

DOI10.1214/10-AOS864zbMath1216.62178arXiv1105.3369WikidataQ42748821 ScholiaQ42748821MaRDI QIDQ548554

Susan A. Murphy, Min Qian

Publication date: 29 June 2011

Published in: The Annals of Statistics (Search for Journal in Brave)

Full work available at URL: https://arxiv.org/abs/1105.3369

zbMATH Keywords

decision making; \(l_1\)-penalized least squares

Mathematics Subject Classification ID

62H99: Multivariate analysis

62P10: Applications of statistics to biology and medical sciences; meta analysis

92C50: Medical applications (general)

62C99: Statistical decision theory

62N02: Estimation in survival analysis and censored data

Related Items

Constrained optimization for stratified treatment rules in reducing hospital readmission rates of diabetic patients, Constrained optimization for stratified treatment rules with multiple responses of survival data, Optimal Treatment Regimes: A Review and Empirical Comparison, Orthogonal statistical learning, A multiagent reinforcement learning framework for off-policy evaluation in two-sided markets, A reluctant additive model framework for interpretable nonlinear individualized treatment rules, Transformation-Invariant Learning of Optimal Individualized Decision Rules with Time-to-Event Outcomes, Statistically Efficient Advantage Learning for Offline Reinforcement Learning in Infinite Horizons, Statistical Learning for Individualized Asset Allocation, Flexible inference of optimal individualized treatment strategy in covariate adjusted randomization with multiple covariates, Estimating heterogeneous treatment effects versus building individualized treatment rules: connection and disconnection, Transfer Learning of Individualized Treatment Rules from Experimental to Real-World Data, Off-policy evaluation in partially observed Markov decision processes under sequential ignorability, Learning Non-monotone Optimal Individualized Treatment Regimes, Transfer learning for contextual multi-armed bandits, Designing optimal, data-driven policies from multisite randomized trials, Dynamic treatment regimes using Bayesian additive regression trees for censored outcomes, Unnamed Item, Unnamed Item, Estimating Individualized Treatment Rules Using Outcome Weighted Learning, Functional Feature Construction for Individualized Treatment Regimes, Quantile-Optimal Treatment Regimes, Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: With an Application to Treating Type 2 Diabetes Patients With Insulin Therapies, Unnamed Item, A Robust Method for Estimating Optimal Treatment Regimes, A Simple Method for Estimating Interactions Between a Treatment and a Large Number of Covariates, More Efficient Policy Learning via Optimal Retargeting, Learning Optimal Distributionally Robust Individualized Treatment Rules, Discussion of Kallus (2020) and Mo et al. (2020), Unnamed Item, Unnamed Item, Unnamed Item, Data-guided Treatment Recommendation with Feature Scores, Multiple Domain and Multiple Kernel Outcome-Weighted Learning for Estimating Individualized Treatment Regimes, Multi-response based personalized treatment selection with data from crossover designs for multiple treatments, A Single-Index Model With a Surface-Link for Optimizing Individualized Dose Rules, Min-Max Optimal Design of Two-Armed Trials with Side Information, A Sparse Random Projection-Based Test for Overall Qualitative Treatment Effects, iFusion: Individualized Fusion Learning, Multi-Armed Angle-Based Direct Learning for Estimating Optimal Individualized Treatment Rules With Various Outcomes, A Sequential Significance Test for Treatment by Covariate Interactions, COMBINING ESTIMATES OF CONDITIONAL TREATMENT EFFECTS, Estimation of Individualized Decision Rules Based on an Optimized Covariate-Dependent Equivalent of Random Outcomes, Proper Inference for Value Function in High-Dimensional Q-Learning for Dynamic Treatment Regimes, Focused information criterion on predictive models in personalized medicine, Greedy outcome weighted tree learning of optimal personalized treatment rules, Estimation of Optimal Individualized Treatment Rules Using a Covariate-Specific Treatment Effect Curve With High-Dimensional Covariates, A Two-Part Framework for Estimating Individualized Treatment Rules From Semicontinuous Outcomes, A Semiparametric Instrumental Variable Approach to Optimal Treatment Regimes Under Endogeneity, Learning Individualized Treatment Rules for Multiple-Domain Latent Outcomes, Stochastic Tree Search for Estimating Optimal Dynamic Treatment Regimes, Optimal Individualized Decision Rules Using Instrumental Variable Methods, Rejoinder: Optimal Individualized Decision Rules Using Instrumental Variable Methods, Improved Doubly Robust Estimation in Learning Optimal Individualized Treatment Rules, Selecting and Ranking Individualized Treatment Rules With Unmeasured Confounding, Personalized Policy Learning Using Longitudinal Mobile Health Data, Deep advantage learning for optimal dynamic treatment regime, Personalised treatment assignment maximising expected benefit with smooth hinge loss, Treatment recommendation and parameter estimation under single-index contrast function, A Semiparametric Approach to Model Effect Modification, Resampling‐based confidence intervals for model‐free robust inference on optimal treatment regimes, A constrained single‐index regression for estimating interactions between a treatment and covariates, Nonparametric Estimation of Conditional Expectation with Auxiliary Information and Dimension Reduction, High-Dimensional Precision Medicine From Patient-Derived Xenografts, On using electronic health records to improve optimal treatment rules in randomized trials, Estimating individualized treatment rules with risk constraint, Adaptive treatment and robust control, Optimal designs for the development of personalized treatment rules, Identifying individual predictive factors for treatment efficacy, On estimating optimal regime for treatment initiation time based on restricted mean residual lifetime, Dynamic Causal Effects Evaluation in A/B Testing with a Reinforcement Learning Framework, On Robustness of Individualized Decision Rules, Net benefit index: Assessing the influence of a biomarker for individualized treatment rules, Estimating the optimal individualized treatment rule from a cost‐effectiveness perspective, Functional additive models for optimizing individualized treatment rules, Model-Assisted Uniformly Honest Inference for Optimal Treatment Regimes in High Dimension, Individualized Group Learning, Personalized treatment selection using observational data, Experimental Evaluation of Individualized Treatment Rules, A single-index model with multiple-links, Estimating treatment effect heterogeneity in randomized program evaluation, Sequential Advantage Selection for Optimal Treatment Regimes, Statistical inference for the mean outcome under a possibly non-unique optimal treatment strategy, Discussion of ``Dynamic treatment regimes: technical challenges and applications, Rejoinder of ``Dynamic treatment regimes: technical challenges and applications, Performance guarantees for individualized treatment rules, A rank-based approach to estimating monotone individualized two treatment regimes, D-learning to estimate optimal individual treatment rules, High-dimensional \(A\)-learning for optimal dynamic treatment regimes, High-dimensional inference for personalized treatment decision, Optimal designs for dose-response models with linear effects of covariates, Variable selection for estimating the optimal treatment regimes in the presence of a large number of covariates, Generalization error bounds of dynamic treatment regimes in penalized regression-based learning, Optimal designs for semi-parametric dose-response models under random contamination, Subgroup identification and variable selection for treatment decision making, Estimating individualized treatment rules for treatments with hierarchical structure, Augmented direct learning for conditional average treatment effect estimation with double robustness, Performance guarantees for policy learning, On a necessary and sufficient identification condition of optimal treatment regimes with an instrumental variable, Diagnosis-group-specific transitional care program recommendations for 30-day rehospitalization reduction, The use of covariates and random effects in evaluating predictive biomarkers under a potential outcome framework, On testing conditional qualitative treatment effects, Fused comparative intervention scoring for heterogeneity of longitudinal intervention effects, Concordance and value information criteria for optimal treatment decision, Regularized outcome weighted subgroup identification for differential treatment effects, Treatment decisions based on scalar and functional baseline covariates, Using decision lists to construct interpretable and parsimonious treatment regimes, A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studies, Evaluating marker-guided treatment selection strategies, Combining biomarkers to optimize patient treatment recommendations, Towards Min Max Generalization in Reinforcement Learning, Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules, Interpretable Dynamic Treatment Regimes, Matched Learning for Optimizing Individualized Treatment Strategies Using Electronic Health Records, An Algorithm for Generating Individualized Treatment Decision Trees and Random Forests, Identifying optimal biomarker combinations for treatment selection via a robust kernel method

Cites Work

• Unnamed Item
• Unnamed Item
• Unnamed Item
• Unnamed Item
• The Adaptive Lasso and Its Oracle Properties
• Performance guarantees for individualized treatment rules
• Evaluating subject-level incremental values of new markers for risk classification rule
• Sparsity in penalized empirical risk minimization
• The sparsity and bias of the LASSO selection in high-dimensional linear regression
• Smooth discrimination analysis
• Optimal aggregation of classifiers in statistical learning.
• Measuring mass concentrations and estimating density contour clusters -- An excess mass approach
• Simultaneous analysis of Lasso and Dantzig selector
• High-dimensional generalized linear models and the lasso
• Sparsity oracle inequalities for the Lasso
• Estimation of Survival Distributions of Treatment Policies in Two-Stage Randomization Designs in Clinical Trials
• History-Adjusted Marginal Structural Models and Statically-Optimal Dynamic Treatment Regimens
• Calibrating parametric subject-specific risk estimation
• FAST RATES FOR ESTIMATION ERROR AND ORACLE INEQUALITIES FOR MODEL SELECTION
• Ideal spatial adaptation by wavelet shrinkage
• Variable Selection via Nonconcave Penalized Likelihood and its Oracle Properties
• Marginal Mean Models for Dynamic Regimes
• Selecting Therapeutic Strategies Based on Efficacy and Death in Multicourse Clinical Trials
• Optimal Dynamic Treatment Regimes
• Optimal Structural Nested Models for Optimal Sequential Decisions
• Semiparametric efficient estimation of survival distributions in two-stage randomisation designs in clinical trials with censored data
• Convexity, Classification, and Risk Bounds